Back to
Impax Asset Management Group plc
LGND
30 quarters
Position history for
Impax Asset Management Group plc's holdings in Ligand Pharmaceuticals Incorporated
Yes. Impax Asset Management Group holds 130,000 shares of LGND (Ligand Pharmaceuticals), worth $41.1M, as of its Q2 2026 13F filing. It reduced the position by 22,444 shares (-14.7%) from Q1 2026. Impax Asset Management Group has held LGND in every 13F on record since Q1 2019, 30 quarterly filings. LGND is 0.3% of Impax Asset Management Group's reported 13F portfolio.
Current Value
$41.1M
Current Shares
130,000
Total Value Change
+$30.9M
Total Shares Change
+49,041
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.